Pharming Group N.V.
PHGUF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,003,568 | $787,920 | $602,141 | $667,723 |
| - Cash | $112,753 | $92,091 | $60,093 | $54,944 |
| + Debt | $111,519 | $128,326 | $119,143 | $112,313 |
| Enterprise Value | $1,002,334 | $824,155 | $661,191 | $725,092 |
| Revenue | $97,287 | $93,221 | $79,094 | $92,672 |
| % Growth | 4.4% | 17.9% | -14.7% | – |
| Gross Profit | $90,216 | $84,249 | $70,771 | $80,459 |
| % Margin | 92.7% | 90.4% | 89.5% | 86.8% |
| EBITDA | $23,430 | $9,785 | -$4,108 | $15,626 |
| % Margin | 24.1% | 10.5% | -5.2% | 16.9% |
| Net Income | $7,548 | $4,694 | -$14,719 | $3,591 |
| % Margin | 7.8% | 5% | -18.6% | 3.9% |
| EPS Diluted | 0.011 | 0.007 | -0.022 | 0.005 |
| % Growth | 61.4% | 131.8% | -540% | – |
| Operating Cash Flow | $30,010 | $11,743 | $232 | $9,331 |
| Capital Expenditures | -$69 | -$128 | -$288 | -$128 |
| Free Cash Flow | $29,941 | $11,615 | -$56 | $9,195 |